Stock A044960 EAGLE VETERINARY TECHNOLOGY CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials Eagle Veterinary Technology Co.,Ltd

Equities

A044960

KR7044960003

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-07-02 EDT 		5-day change 1st Jan Change
5,320 KRW -0.19% Intraday chart for Eagle Veterinary Technology Co.,Ltd -0.93% -3.27%
2023 Eagle Veterinary Technology Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
2017 Tranche Update on Eagle Veterinary Technology Co.,Ltd's Equity Buyback Plan announced on November 3, 2016. CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 47,597 84,827 128,315 99,239 69,025 69,530
Enterprise Value (EV) 1 53,879 89,332 128,705 96,042 70,588 70,997
P/E ratio 44.4 x 66.8 x 50.7 x 26.5 x 25.4 x 22.7 x
Yield - - - - - -
Capitalization / Revenue 1.57 x 2.46 x 3.18 x 2.45 x 1.59 x 1.62 x
EV / Revenue 1.78 x 2.6 x 3.19 x 2.38 x 1.62 x 1.66 x
EV / EBITDA 18.3 x 23.8 x 24 x 19.3 x 15.2 x 15.8 x
EV / FCF 99.9 x 66 x 22.2 x 21.3 x -54 x -272 x
FCF Yield 1% 1.52% 4.5% 4.68% -1.85% -0.37%
Price to Book 1.34 x 2.32 x 3.3 x 2.36 x 1.56 x 1.49 x
Nbr of stocks (in thousands) 12,642 12,642 12,642 12,642 12,642 12,642
Reference price 2 3,765 6,710 10,150 7,850 5,460 5,500
Announcement Date 19-03-01 20-02-29 21-03-01 22-03-01 23-03-01 24-02-29
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 30,262 34,423 40,357 40,437 43,540 42,794
EBITDA 1 2,946 3,755 5,369 4,988 4,653 4,501
EBIT 1 1,110 1,612 3,419 3,518 3,409 3,315
Operating Margin 3.67% 4.68% 8.47% 8.7% 7.83% 7.75%
Earnings before Tax (EBT) 1 1,105 1,264 2,929 3,875 3,429 3,520
Net income 1 1,042 1,232 2,459 3,638 2,643 2,976
Net margin 3.44% 3.58% 6.09% 9% 6.07% 6.95%
EPS 2 84.88 100.4 200.3 296.4 215.3 242.4
Free Cash Flow 1 539.2 1,354 5,794 4,499 -1,308 -261
FCF margin 1.78% 3.93% 14.36% 11.13% -3% -0.61%
FCF Conversion (EBITDA) 18.3% 36.06% 107.91% 90.2% - -
FCF Conversion (Net income) 51.75% 109.9% 235.65% 123.68% - -
Dividend per Share - - - - - -
Announcement Date 19-03-01 20-02-29 21-03-01 22-03-01 23-03-01 24-02-29
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 6,283 4,505 390 - 1,563 1,467
Net Cash position 1 - - - 3,196 - -
Leverage (Debt/EBITDA) 2.133 x 1.2 x 0.0726 x - 0.336 x 0.3259 x
Free Cash Flow 1 539 1,354 5,794 4,499 -1,308 -261
ROE (net income / shareholders' equity) 3.14% 3.52% 6.71% 9.26% 6.31% 6.74%
ROA (Net income/ Total Assets) 1.45% 2.19% 4.53% 4.35% 3.97% 3.66%
Assets 1 71,985 56,291 54,278 83,561 66,663 81,398
Book Value Per Share 2 2,814 2,895 3,074 3,326 3,499 3,694
Cash Flow per Share 2 36.60 136.0 430.0 188.0 141.0 214.0
Capex 1 1,259 379 785 186 387 4,530
Capex / Sales 4.16% 1.1% 1.94% 0.46% 0.89% 10.58%
Announcement Date 19-03-01 20-02-29 21-03-01 22-03-01 23-03-01 24-02-29
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Veterinary Drugs

1st Jan change Capi.
EAGLE VETERINARY TECHNOLOGY CO.,LTD Stock Eagle Veterinary Technology Co.,Ltd
-3.27% 48.63M
ELANCO ANIMAL HEALTH INCORPORATED Stock Elanco Animal Health Incorporated
-5.17% 6.92B
BLUESTAR ADISSEO COMPANY Stock Bluestar Adisseo Company
+21.62% 3.6B
VIRBAC Stock Virbac
-3.20% 3.03B
VIMIAN GROUP AB Stock Vimian Group AB
+13.01% 1.64B
VETOQUINOL SA Stock Vetoquinol SA
-9.18% 1.19B
JINYU BIO-TECHNOLOGY CO., LTD. Stock Jinyu Bio-technology Co., Ltd.
-34.91% 1.1B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD. Stock China Animal Husbandry Industry Co., Ltd.
-36.76% 1.05B
WUHAN KEQIAN BIOLOGY CO.,LTD Stock Wuhan Keqian Biology Co.,Ltd
-32.83% 895M
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD. Stock Tianjin Ringpu Bio-Technology Co.,Ltd.
-17.45% 872M
Veterinary Drugs
  1. Stock Market
  2. Equities
  3. A044960 Stock
  4. Financials Eagle Veterinary Technology Co.,Ltd